Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced ...

Solvay has amended its €1.1 billion multilateral revolving credit facility and its €0.3 billion bilateral revolving credit facilities to incorporate sustainability-linked features, aligning with its ...

MILAN, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Fitch has upgraded Intesa Sanpaolo’s credit rating by two notches to A-. For the first time, Fitch rated the Group one notch above Italy’s sovereign rating.

Inside Information: Pihlajalinna plans to reform its operating model to ensure development and growth in line with the strategy ...

Nokia positioned as a Leader in a Gartner Magic Quadrant for 5G for fifth consecutive year.

Thomas Kim, an award-winning top producer in Korea’s traditional brokerage system, now leads eXp Korea with a focus on helping agents grow their businesses through innovation, mentorship, and a truly ...

Zug, Switzerland. 25 September 2025 – PLAN-B NET ZERO AG, an innovative greentech company in the neo-energy sector, has successfully completed a capital increase of CHF 4.5 million. The company's ...

Josh Payne, CEO of Nscale, said: “We are focused on building the next generation of AI infrastructure, and strong partnerships are central to that effort. Nokia brings proven expertise in networking ...

Six of the EU´s top ten vehicle-producing countries recorded double-digit losses. This is according to the World Robotics 2025 Industrial Robots report, presented by the International Federation of ...

Under the terms of the agreement, Cana will manufacture MYCOFAGYL®, a combination of Metronidazole (500mg) and Nystatin (100,000 IU) in pessary dosage form. The product will be supplied in packs of 10 ...

Primetals Technologies, together with its project partners Rio Tinto, a global mining and metals company and one of the world’s leading producers of iron ore, and globally leading steel and technology ...

Numab to receive first milestone payment. Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclin ...